Kiaxone S 1mg/500mg Injection
Marketer
Alicanto Drugs Pvt Ltd
Salt Composition
Ceftriaxone (1mg) + Sulbactam (500mg)
Overview Kiaxone S 1mg/500mg Injection
Combix 1mg/500mg Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, thereby curbing infection spread. Administration must be strictly under a physician's guidance; adhere to all scheduled doses. Complete the prescribed course, even with symptom improvement; premature cessation compromises efficacy. Common side effects may include nausea, vomiting, diarrhea, and dyspepsia. Report worsening side effects immediately. Seek urgent medical attention for allergic reactions (rash, pruritus, edema, dyspnea). Disclose all current medications to your doctor before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, avoid driving if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and ample hydration are crucial for optimal recovery. Your physician may order blood tests and other diagnostics to monitor treatment response.
Uses of Kiaxone S 1mg/500mg Injection
Infections caused by bacteria
Major Benefits of Kiaxone S 1mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Kiaxone S 1mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Kiaxone S 1mg/500mg Injection:
This medication will be administered by your physician or their qualified staff. Self-medication is strongly discouraged.
How Kiaxone S 1mg/500mg Injection works:
Kiaxone S Injection (1mg/500mg) unites Ceftriaxone, a crucial antibiotic, with Sulbactam, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a vital process for bacterial viability. Sulbactam's role is to counter bacterial resistance, thereby optimizing Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of alcohol and Kiaxone S 1mg/500mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Kiaxone S 1mg/500mg Injection is typically deemed safe. Preclinical trials in animals revealed minimal or no harm to fetuses; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Kiaxone S 1mg/500mg Injection necessitates prudence while breastfeeding. Lactation should be temporarily discontinued until maternal treatment concludes and the medication is fully cleared from the patient's system.
DrivingUNSAFE
Kiaxone S 1mg/500mg Injection can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these side effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Kiaxone S 1mg/500mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
Individuals with severe hepatic impairment should use Kiaxone S 1mg/500mg Injection cautiously; dosage modification may be necessary. Medical advice is recommended. Dosage alteration for Kiaxone S 1mg/500mg Injection is not advised for those with mild to moderate liver dysfunction.
What if you forget to take Kiaxone S 1mg/500mg Injection :
Omit a Kiaxone S 1mg/500mg Injection dose? Seek medical advice immediately.
Facts to Know About Kiaxone S 1mg/500mg Injection
| Label | Value |
|---|---|
| Addictive | None. |
| Medication Classification | Antimicrobial agents |
3,018 People bought this recently